Analyst Katie Tryhane works at CREDIT SUISSE and is covering the the Healthcare sector with 14 price targets and ratings documented since 2018 spanning on 1 stocks.
Katie Tryhane's average stock forecast success ratio is 71.43% with an average time for price targets to be met of 31 days.
Most recent stock forecast was given on CRL, Charles River Laboratories International, Inc at 25-Aug-2022.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC) at 8/21/2018. The price target of $121 was fulfilled within 2 days with a profit of $0.83 (0.69%) receiving and performance score of 3.45.
Average potential price target upside
Currently, out of the existing stock ratings of Katie Tryhane - 6 which are a Hold (75%), 2 which are a Buy (25%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
225
$31.62 (16.35%)
230
17 days ago
13/18 (72.22%)
$34.42 (12.26%)
102
Buy
255
$61.62 (31.86%)
260
20 days ago
2/7 (28.57%)
$51.15 (21.85%)
89
Buy
280
$86.62 (44.79%)
300
20 days ago
2/5 (40%)
$54.48 (26.79%)
88
Hold
203
$9.62 (4.97%)
233
2 months 4 days ago
22/24 (91.67%)
$20.3 (17.56%)
181
Buy
285
$91.62 (47.38%)
461
4 months 21 days ago
5/7 (71.43%)
$27.82 (11.71%)
96
